Figure 5.
The normalized percentage deviation of the dose parameters as a function of planning target volume size: (a) for nondetached lung treatment plans (n = 23) (b) for detached lung treatment plans (n = 21), (c) for pancreas treatment plans (n = 15), (d) for intracranial treatment plans (n = 21). Triangle: D95, Circle: Dmean, Square: Dmax
